Treg Therapy for the Induction of Immune Tolerance in Transplantation—Not Lost in Translation?
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24021752 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Nina Pilat und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Medical University of Vienna, 1090 Vienna, Austria. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Organ Transplantation. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF, FWF Austrian Science Fund.
Abstract (Originalsprache)
The clinical success of solid organ transplantation is still limited by the insufficiency of immunosuppressive regimens to control chronic rejection and late graft loss. Moreover, serious side effects caused by chronic immunosuppressive treatment increase morbidity and mortality in transplant patients. Regulatory T cells (Tregs) have proven to be efficient in the induction of allograft tolerance and prolongation of graft survival in numerous preclinical models, and treatment has now moved to the clinics. The results of the first Treg-based clinical trials seem promising, proving the feasibility and safety of Treg therapy in clinical organ transplantation. However, many questions regarding Treg phenotype, optimum dosage, antigen-specificity, adjunct immunosuppressants and efficacy remain open. This review summarizes the results of the first Treg-based clinical trials for tolerance induction in solid organ transplantation and recapitulates what we have learnt so far and which questions need to be resolved before Treg therapy can become part of daily clinical practice. In addition, we discuss new strategies being developed for induction of donor-specific tolerance in solid organ transplantation with the clinical aims of prolonged graft survival and minimization of immunosuppression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiac Surgery, Medical University of Vienna, 1090 Vienna, Austria.
- Center for Biomedical Research, Medical University of Vienna, 1090 Vienna, Austria.
- Immunology Division, Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia.
- St Vincent's Clinical School, University of New South Wales, Sydney, NSW 2010, Australia.
ORCID-Profile: Nina Pilat, Romy Steiner, Jonathan Sprent
Förderung
- Austrian Science Fund FWF
- FWF Austrian Science Fund
Zitieren
APA
Pilat, N., Steiner, R., & Sprent, J. (2023). Treg Therapy for the Induction of Immune Tolerance in Transplantation—Not Lost in Translation?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021752
Vancouver
Pilat N, Steiner R, Sprent J. Treg Therapy for the Induction of Immune Tolerance in Transplantation—Not Lost in Translation?. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021752
BibTeX
@article{Pilat2023,
author = {Pilat, Nina and Steiner, Romy and Sprent, Jonathan},
title = {Treg Therapy for the Induction of Immune Tolerance in Transplantation—Not Lost in Translation?},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24021752}
}
EUVIMED